2026-09-292026-09-29https://scholars.csmu.edu.tw/handle/123456789/19481Tamoxifen, a selective estrogen-receptor modulator (SERM), has extensively been used for the treatment of estrogen receptor α (ERα)-positive breast cancer that functions as an antagonist to compet...(詳)Tamoxifen 是一種選擇性雌激素受體調節劑，廣泛用於治療雌激素受體α (estrogen receptor α，ERα) 陽性乳癌，其藥理作用為競爭性結合的ERα拮抗抑制劑，可抑制ERα...(詳)tamoxifen (泰莫西芬)trans 354'-trimethoxystilbene (MR-3)雌激素受體α (estrogen receptor αERα)上皮細胞-間質細胞轉換Wntβ-cateninphosphatidylinositol 3-kinase (PI3K)Akttamoxifentrans 354'-trimethoxystilbene (MR-3)estrogen receptor α (ERα)epithelial-mesenchymal transition (EMT)Wntβ-cateninphosphatidylinositol 3-kinase (PI3K)AktProject